See also this year's filing and all EDGAR filings for this company.
PDF Report 0001107421_2017_Alaunos_Therapeutics_Inc.pdf
Logs
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001107421', 'EntityCommonStockSharesOutstanding': 132376670, 'Assets': 106348000, 'AssetsCurrent': 104884000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 58325000, 'LiabilitiesAndStockholdersEquity': 106348000, 'LiabilitiesCurrent': 15809000, 'LiabilitiesNoncurrent': 0, 'NetIncome': -165297000, 'PropertyPlantAndEquipmentNet': 843000, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'TemporaryEquity': 0, 'remainder_Assets': 621000, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 42516000, 'remainder_LiabilitiesAndStockholdersEquity': -77298000, 'remainder_NetIncome': -165049000, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001107421')"} |
Edgar->Model Mapping
